Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 21
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Marshall, Max Barrowclough, Christine Drake, Richard Husain, Nusrat Lobban, Fiona Lovell, Karina Wearden, Alison Bradshaw, Tim Day, Christine Fitzsimmons, Mike Pedley, Rebecca Piccuci, Ruth Picken, Alicia Larkin, Warren Tomenson, Barbara Warburton, Jeff and Gregg, Lynsey 2015. The HELPER programme: HEalthy Living and Prevention of Early Relapse – three exploratory randomised controlled trials of phase-specific interventions in first-episode psychosis. Programme Grants for Applied Research, Vol. 3, Issue. 2, p. 1.

    Dopke, Cynthia A. and Batscha, Catherine L. 2014. Cognitive-Behavioral Therapy for Individuals with Schizophrenia: A Recovery Approach. American Journal of Psychiatric Rehabilitation, Vol. 17, Issue. 1, p. 44.

    Drake, R. J. Day, C. J. Picucci, R. Warburton, J. Larkin, W. Husain, N. Reeder, C. Wykes, T. and Marshall, M. 2014. A naturalistic, randomized, controlled trial combining cognitive remediation with cognitive–behavioural therapy after first-episode non-affective psychosis. Psychological Medicine, Vol. 44, Issue. 09, p. 1889.

    Hill, Kimberley and Startup, Mike 2013. The relationship between internalized stigma, negative symptoms and social functioning in schizophrenia: The mediating role of self-efficacy. Psychiatry Research, Vol. 206, Issue. 2-3, p. 151.

    Rado, Jeffrey T. Hernandez, Edgar I. and Janicak, Philip G. 2013. Novel Approaches for Managing Schizophrenia. Psychopharm Review, Vol. 48, Issue. 11, p. 81.

    Jones, Christopher and Meaden, Alan 2012. Handbook of Evidence-Based Practice in Clinical Psychology.

    Rosenbaum, Bent Harder, Susanne Knudsen, Per Køster, Anne Lindhardt, Anne Lajer, Matilde Valbak, Kristian and Winther, Gerda 2012. Supportive Psychodynamic Psychotherapy versus Treatment as Usual for First-Episode Psychosis: Two-Year Outcome. Psychiatry: Interpersonal and Biological Processes, Vol. 75, Issue. 4, p. 331.

    Steel, Craig Taylor, Rumina and Wykes, Til 2012. Pharmacological and Psychosocial Treatments in Schizophrenia.

    Steel, Craig and Taylor, Rumina 2012. Pharmacological and Psychosocial Treatments in Schizophrenia, Third Edition.

    Felmet, Kandi Zisook, Sidney and Kasckow, John 2011. Elderly Patients with Schizophrenia and Depression: Diagnosis and Treatment. Clinical Schizophrenia & Related Psychoses, Vol. 4, Issue. 4, p. 239.

    Gaynor, Keith Dooley, Barbara Lawlor, Elizabeth Lawoyin, Richard and O'Callaghan, Eadbhard 2011. Group cognitive behavioural therapy as a treatment for negative symptoms in first-episode psychosis. Early Intervention in Psychiatry, Vol. 5, Issue. 2, p. 168.

    Jolley, Suzanne and Garety, Philippa 2011. Schizophrenia.

    Kaiser, Stefan Heekeren, Karsten and Simon, Joe J. 2011. The Negative Symptoms of Schizophrenia: Category or Continuum?. Psychopathology, Vol. 44, Issue. 6, p. 345.

    van der Gaag, M. Stant, A. D. Wolters, K. J. K. Buskens, E. and Wiersma, D. 2011. Cognitive-behavioural therapy for persistent and recurrent psychosis in people with schizophrenia-spectrum disorder: cost-effectiveness analysis. The British Journal of Psychiatry, Vol. 198, Issue. 1, p. 59.

    Dixon, L. B. Dickerson, F. Bellack, A. S. Bennett, M. Dickinson, D. Goldberg, R. W. Lehman, A. Tenhula, W. N. Calmes, C. Pasillas, R. M. Peer, J. and Kreyenbuhl, J. 2010. The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements. Schizophrenia Bulletin, Vol. 36, Issue. 1, p. 48.

    Startup, Mike Jackson, Mike C. and Startup, Sue 2010. Insight, social functioning and readmission to hospital in patients with schizophrenia-spectrum disorders: Prospective associations. Psychiatry Research, Vol. 178, Issue. 1, p. 17.

    Avery, Rachel Startup, Mike and Calabria, Karen 2009. The role of effort, cognitive expectancy appraisals and coping style in the maintenance of the negative symptoms of schizophrenia. Psychiatry Research, Vol. 167, Issue. 1-2, p. 36.

    Saksa, John R. Cohen, Shuki J. Srihari, Vinod H. and Woods, Scott W. 2009. Cognitive Behavior Therapy for Early Psychosis: A Comprehensive Review of Individual vs. Group Treatment Studies. International Journal of Group Psychotherapy, Vol. 59, Issue. 3, p. 357.

    Lecomte, Tania Leclerc, Claude Corbière, Marc Wykes, Til Wallace, Charles J. and Spidel, Alicia 2008. Group Cognitive Behavior Therapy or Social Skills Training for Individuals With a Recent Onset of Psychosis?. The Journal of Nervous and Mental Disease, Vol. 196, Issue. 12, p. 866.

    Smith, Gina and Steel, Craig 2008. Pharmacological and Psychosocial Treatments in Schizophrenia.


North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation

  • DOI:
  • Published online: 01 September 2005

Background. There is good evidence now that cognitive behaviour therapy (CBT) is effective in the treatment of people suffering from schizophrenia. There is also some evidence that the benefits of CBT persist after the end of treatment and that the direct costs of providing CBT as an adjunct to standard care are no higher than the direct costs of standard care alone. The aims of the present study were to discover if the benefits of CBT for acute schizophrenia which were found 1 year after index admission persist for another year, and to evaluate the comparative costs of providing CBT.

Method. Consecutive admissions meeting criteria were recruited. After screening, 43 were assigned at random to a treatment-as-usual (TAU) control group and 47 were assigned to TAU plus CBT. Patients (73% of original) were rated on symptoms and social functioning 2 years after index admission. An evaluation of the direct costs of services was also completed.

Results. The CBT group had maintained its advantage over the TAU group on negative symptoms and social functioning but had lost the advantage it previously enjoyed in positive symptoms. The difference between groups in total direct costs over the 2 years was not statistically significant despite the cost of providing CBT.

Conclusions. Some of the benefits of CBT for patients suffering acute psychotic episodes persist for 2 years. After the end of regular treatment, CBT should probably be targeted on the appearance of early signs of relapse to forestall the re-emergence of positive symptoms.

Corresponding author
School of Behavioural Sciences, University of Newcastle, Callaghan, NSW 2308, Australia. (Email:
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *